Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
deals
detroit blog main
detroit top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
3
×
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
covid-19
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
national
novartis
takeda pharmaceutical
unity biotechnology
accelerator
What
sciences
3
×
acquisitions
bio
ceo
daniel
gilead
o’day
roundup
years
admits
ago
announced
big
biggest
biotechs
build
buy
classes
collabs
combinator
companies
company’s
covid
deal
debut
drug
dug
dyne’s
gilead’s
help
incubator
introduce
ipo
life
medicines
microbiome
month
moves
openly
pipeline
Language
unset
3
×
Current search:
sciences
×
unset
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In